Blood-Brain Barrier Imaging in Human Neuropathologies

被引:43
|
作者
Veksler, Ronel [1 ,2 ]
Shelef, Ilan [3 ,4 ]
Friedman, Alon [1 ,2 ,5 ]
机构
[1] Soroka Univ, Med Ctr, Zlotowski Ctr Neurosci, Dept Physiol & Cell Biol, Beer Sheva, Israel
[2] Soroka Univ, Med Ctr, Zlotowski Ctr Neurosci, Dept Brain & Cognit Sci, Beer Sheva, Israel
[3] Soroka Univ, Med Ctr, Dept Med Imaging, Beer Sheva, Israel
[4] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel
[5] Dalhousie Univ, Fac Med, Dept Med Neurosci, Halifax, NS B3H 4R2, Canada
基金
以色列科学基金会; 美国国家卫生研究院;
关键词
Blood-brain barrier; Magnetic resonance; Neuropathologies; Neurovascular; ARTERIAL INPUT FUNCTION; CONTRAST-ENHANCED MRI; SMALL VESSEL DISEASE; HIGH-GRADE GLIOMAS; DCE-MRI; HEMORRHAGIC TRANSFORMATION; TEMPORAL-RESOLUTION; KINETIC-PARAMETERS; DISRUPTION; PERMEABILITY;
D O I
10.1016/j.arcmed.2014.11.016
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The blood-brain barrier (BBB) is essential for normal function of the brain, and its role in many brain pathologies has been the focus of numerous studies during the last decades. Dysfunction of the BBB is not only being shown in numerous brain diseases, but animal studies have indicated that it plays a direct key role in the genesis of neurovascular dysfunction and associated neurodegeneration. As such evidence accumulates, the need for robust and clinically applicable methods for minimally invasive assessment of BBB integrity is becoming urgent. This review provides an introduction to BBB imaging methods in the clinical scenario. First, imaging modalities are reviewed, with a focus on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). We then proceed to review image analysis methods, including quantitative and semi-quantitative methods. The advantages and limitations of each approach are discussed, and future directions and questions are highlighted. (C) 2014 IMSS. Published by Elsevier Inc.
引用
收藏
页码:646 / 652
页数:7
相关论文
共 50 条
  • [1] Imaging P-glycoprotein at the human blood-brain barrier
    Franssen, Eric J. F.
    Luurtsema, Gert
    Lammertsma, Adriaan A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (03) : 302 - 303
  • [2] Blood-brain barrier permeable antibodies for brain imaging
    van den Broek, Sara Lopes
    Syvaenen, Stina
    Sehlin, Dag
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S134 - S135
  • [3] Imaging P-glycoprotein at the human blood-brain barrier - Reply
    Unadkat, Jashvant D.
    Link, Jeanne M.
    Mankoff, David A.
    Muzi, Mark
    Collier, Ann C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (03) : 303 - 304
  • [4] Pretargeted imaging beyond the blood-brain barrier
    Shalgunov, Vladimir
    van den Broek, Sara Lopes
    Andersen, Ida Vang
    Vazquez, Rocio Garcia
    Raval, Nakul Ravi
    Palner, Mikael
    Mori, Yuki
    Schafer, Gabriela
    Herrmann, Barbara
    Mikula, Hannes
    Beschorner, Natalie
    Nedergaard, Maiken
    Syvanen, Stina
    Barz, Matthias
    Knudsen, Gitte Moos
    Battisti, Umberto Maria
    Herth, Matthias Manfred
    RSC MEDICINAL CHEMISTRY, 2023, 14 (03): : 444 - 453
  • [5] Fluorescence imaging of blood-brain barrier disruption
    Hawkins, BT
    Egleton, RD
    JOURNAL OF NEUROSCIENCE METHODS, 2006, 151 (02) : 262 - 267
  • [6] Blood-brain barrier - Size matters at the blood-brain barrier
    Green, E
    NATURE REVIEWS NEUROSCIENCE, 2003, 4 (07) : 525 - 525
  • [7] Engineering the human blood-brain barrier in vitro
    John J. Jamieson
    Peter C. Searson
    Sharon Gerecht
    Journal of Biological Engineering, 11
  • [8] Human cerebral malaria and the blood-brain barrier
    Medana, Isabelle M.
    Turner, Gareth D. H.
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2006, 36 (05) : 555 - 568
  • [9] Engineering the human blood-brain barrier in vitro
    Jamieson, John J.
    Searson, Peter C.
    Gerecht, Sharon
    JOURNAL OF BIOLOGICAL ENGINEERING, 2017, 11
  • [10] Effects of laquinimod on the human blood-brain barrier
    Kebir, H.
    Prat, A.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S184 - S184